
What drink in the 19th century was created by infusing coca leaves into a bottle of Bordeaux?

What drink in the 19th century was created by infusing coca leaves into a bottle of Bordeaux?

Top news of the week from Pharmacy Times®.

Racial and economic disparities are especially pronounced among patients on Medicare, study shows.

Contrary to earlier statements from the CDC, study suggests corticosteroid inhalers used by many asthmatics might make it more difficult for COVID-19 to enter the airways.

Promoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.

Post-menopausal women are at a heightened risk of Alzheimer disease.

The pandemic is exacerbating many of the conditions that contribute to relapse or people using substances just to cope, including unemployment, stress, fear, anxiety, and isolation.

The results of the study found that adults who experienced 4 common symptoms of anxiety and depression have upwards of 2 times greater risk of delaying medical care or not receiving needed non-COVID-19 medical care amidst the pandemic.

In a phase 3 clinical trial, oral paclitaxel was found to be just as effective intravenous paclitaxel in metastatic breast cancer.

STACK is the industry's only Pharmacy Information Management Platform.

The action is part of a growing movement to expand the ability of pharmacists and pharmacy staff to meet the needs of patients during the COVID-19 pandemic.

Pharmacy Times spoke with Russell Procopio, executive vice president of Long-Term Care Pharmacy, about a new study regarding long-term care outcomes and cost.

The goals of specialty pharmacy programs are to reduce or delay progression of the disease, improve patient outcomes, enhance patients’ quality of life, keep patients in the workforce longer, and decrease total health care costs.

A simple test may be a low-cost way of identifying patients at-risk for type 2 diabetes.

Mailing educational materials to patients with atrial fibrillation and their clinicians did not increase the use of stroke prevention drugs.

With OTC melatonin readily available and its product awareness high among consumers, many pharmacists may be interested in learning more about its safety and efficacy.

Research examines whether immunizations had any link with the risk of heart failure patients dying while in the hospital, since few studies have compared the outcomes of vaccinated and unvaccinated patients.

Weight loss may be able to prevent or reverse type 2 diabetes (T2D), according to research presented at the European Society of Cardiology Congress 2020.

Leader in pharmacy technology to deploy inventory management solution across VA pharmacy network.

Nizatidine Oral Solution is a prescription oral product used for the short-term treatment and maintenance therapy of ulcers and for the treatment of esophagitis and associated heartburn due to GERD.

In a statement, CEO B. Douglas Hoey emphasized the important role pharmacists will play in distributing the vaccine once available.

Using a binding agent to combine therapies can extend their benefits in treating type 2 diabetes.

Study finds that vitamin C may help improve the quality of life in people over 50 years of age.

Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of ADHD.

According to results from a recent study, a functional cure for HIV may lie in identifying the viral reservoirs in which HIV places copies of its viral genetic material into cell genomes.

Patients reported their likeness of having support from a trusted health care professional, rapid feedback, and adjustments to their treatment with someone to be accountable to, according to the study authors.

Research suggests ketogenic and intermittent fasting diets seem to help people lose weight in the short-term, which benefits cardiovascular health.

The current study found no link between personal use of permanent hair dye and the risk of most cancers or cancer-related mortality.

The FDA also granted priority review to pralsetinib for the treatment of patients with advanced or metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer.

A patient has Lynch syndrome, a hereditary condition that puts young people at high risk for colon cancer.